Phase
Condition
Multiple Sclerosis
Dementia
Mental Disability
Treatment
N/AClinical Study ID
Ages 18-59 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Males/Females who are ≥ 18 years old and ≤ 59 years old
Relapsing Remitting, Secondary Progressive or Primary Progressive MS, as per revisedMcDonald's Criteria
Have not received corticosteroids in last thirty days or a relapse in the last ninetydays
An Expanded Disability Status Scale (EDSS) of ≤ 6.5
If female, must neither be pregnant nor breast-feeding
Exclusion
Exclusion Criteria:
- Have evidence of other medical cause(s) of cognitive impairment
Have evidence of major depression as determined by a positive Beck DepressionIndex-Fast screen ≥ 13and/or by clinician interview or evidence of severe fatigue witha Fatigue Severity Scale ≥ 5.
Have demonstrated a hypersensitivity to amphetamines in the past
Have uncontrolled or labile hypertension (> 135/85 mm Hg, treated or untreated)
Have a history of structural heart disease, including atherosclerosis or angina
Have a diagnosis of bipolar disorder or a history of a psychotic episode
The following medications are not permitted to be used within 14 days the study
Monoamine Oxidase Inhibitors
Sympathomimetics or methadone
Antipsychotic agents
Modafinil
- The following medications are permitted if the dose has been stable for ≥ 28 days
Short acting benzodiazepines, qhs administration only
Anticonvulsants, including gabapentin and pregabalin
Bupropion
Tricyclic Antidepressants
Anti-spasmodics such as baclofen or tizanidine
Anticholinergic medication
Selective serotonin(-norepinephrine) reuptake inhibitors
Study Design
Connect with a study center
London Health Sciences Center and St. Joseph's Heathcare Center (Parkwood)
London, Ontario N6G 1W8
CanadaSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.